—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Rigel Pharmaceuticals Inc (RIGL) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for RIGL, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 46/100 · S&P 500 fund at 46, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-23
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 81th percentile of the window, -14.3% over 20 sessions. Factor regime → 2026-10-23
  • Sector × region Health care in US: +1.5% week · +5.5% month · +10.1% quarter · +23.3% yearThe Sector Engine cell this name lives in, from XLV.US; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-24
  • Sovereign pressure Index -1.16 · down 1.91 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-23
How it trades on rate days beta 0.43 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How RIGL has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.43 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Rigel Pharmaceuticals Inc moved 0.43% on average · correlation 0.07 · higher than 35% of US names
  • Beta, last 3 months 0.81 more rate-sensitive lately than over the year
  • On the 10 worst bond days −2.34% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −0.50% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Biotechnology · US · 8 names with week and year-to-date

Peer group

Biotechnology · US

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against RIGL on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

The Street on this name 1 analyst action on the wire · latest: price target by H.C. Wainwright, 2026-08-14

The Street on this name

Analyst actions and the latest print for RIGL from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target H.C. Wainwright — target 85 from 57 Target raised to $85 from $57 (+103.7% to spot) 2026-08-14

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return no distribution in twelve months

Dividends and capital return

What RIGL pays out and buys back — distributions read from the price series, money terms from the filings.

  • Distributions No cash distribution recorded in the price series over the last three years
  • Buybacks, FY2025 none reported
  • Share count +6.5% in FY2025 13 m USD of stock-based compensation in the year

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

About Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL) trades on US exchanges, classified under Healthcare.

The Closelooknet company score reads 62/100 composite (momentum 92, quality 90, valuation 74) across 7 modules — the full three-layer breakdown, chart structure and analog history load live above.

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-10-24

Quick answers

What is Rigel Pharmaceuticals Inc (RIGL)?

Rigel Pharmaceuticals Inc trades as RIGL on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-10-24.

Is RIGL in a Closelooknet index?

Not currently — Rigel Pharmaceuticals Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-24.

What is Rigel Pharmaceuticals Inc's Closelooknet composite score?

62 out of 100, with momentum 92, quality 90 and valuation 74 sub-scores, as of 2026-10-24. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does RIGL trade against its moving averages?

Uptrend stack intact: Trades +2.3% vs the 50-day and +30.5% vs the 200-day average, 7.9% below the 52-week high and +92.9% off the 52-week low; a golden cross printed 66 sessions ago. Computed from daily closes. As of 2026-10-23 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Rigel Pharmaceuticals Inc compare with its peers?

Against its peer group (Biotechnology · US), Rigel Pharmaceuticals Inc (RIGL) sits 7.9% below its 52-week high, 2.3% above its 50-day average; Halozyme Therapeutics Inc (HALO) is 0.5% below, BeiGene, Ltd. (ONC) is 2.8% below, argenx NV ADR (ARGX) is 18.6% below. Put any of them next to RIGL in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Rigel Pharmaceuticals Inc trade when bond yields rise?

Over the past year Rigel Pharmaceuticals Inc had a beta of 0.43 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 35% of US names. On the 10 sessions in which long bonds fell most it moved −2.34% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Does Rigel Pharmaceuticals Inc pay a dividend?

No cash distribution shows in Rigel Pharmaceuticals Inc’s price series over the last three years. The share count rose 6.5% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Rigel Pharmaceuticals Inc recently?

The most recent analyst action on Rigel Pharmaceuticals Inc on the Closelooknet wire is a price target by H.C. Wainwright on 2026-08-14 (target 85 from 57). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for RIGL, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.